ArticleCell reports2025
Mitochondrial Ca
Abstract read
In one paragraph
Article in Cell reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Epithelial-mesenchymal transition in carcinoma: navigating phenotypic states to target resistance and metastasis.Cancer metastasis reviews · 2026Review
- Role of epithelial-mesenchymal transition (EMT) in malignancies: current status and future prospects.Signal transduction and targeted therapy · 2026Review
- Integrated computational and in vitro investigation to explore the preliminary anti-proliferative and anti-mitotic potential of γ-oryzanol against breast cancer.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Mitochondria-Associated Endoplasmic Reticulum Membranes in Cancer: Hubs for Tumor Progression and Therapeutic Vulnerabilities.Cell biology international · 2026Review
- Article
- Prognostic significance of calcium signaling-related genes in bladder cancer and the role of ATP2B4 in regulating mitochondrial calcium ion levels via the VDAC1/MCU pathway.Frontiers in immunology · 2026Article
- Genomic and Transcriptomic Landscapes of MEN1-Wild-Type Low-Grade Metastatic Pancreatic NETs Uncover Key Oncogenic Drivers and Targetable Pathways.International journal of biological sciences · 2026Article
- Mitochondrial CaJournal of cellular physiology · 2025Review
- Mitochondrial metabolism and cancer therapeutic innovation.Signal transduction and targeted therapy · 2025Review
- Metabolic plasticity in pancreatic cancer: The mitochondrial connection.Molecular metabolism · 2025Review
Corrections and comments
- Update ofMitochondrial Ca2024
Authors and funding
15 authors.
Jillian S WeissenriederDepartment of Physiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Jessica PeuraDivision of Hematology/Oncology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA; Department of Molecular, Cell, and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Usha PaudelDepartment of Physiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Nikita BhaleraoDivision of Hematology/Oncology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA; Department of Molecular, Cell, and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Natalie WeinmannDepartment of Chemistry, Millersville University, Millersville, PA, USA.
Calvin JohnsonDivision of Hematology/Oncology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA; Department of Molecular, Cell, and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Maximilian WengynDivision of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104-5157, USA.
Rebecca DragerDepartment of Chemistry, The Ohio State University, Columbus, OH, USA.
Emma Elizabeth FurthDepartment of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Karl SiminDepartment of Molecular, Cell, and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Marcus RuscettiDepartment of Molecular, Cell, and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Ben Z StangerDivision of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104-5157, USA.
Anil K RustgiHerbert Irving Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Medicine, Columbia University Irving Medical Center, New York City, NY 10032, USA.
Jason R PitarresiDivision of Hematology/Oncology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA; Department of Molecular, Cell, and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA. Electronic address: jason.pitarresi@umassmed.edu.
J Kevin FoskettDepartment of Physiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Department of Cell and Developmental Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. Electronic address: foskett@pennmedicine.upenn.edu.
Funding
TRANSGENIC AND CHIMERIC MOUSE COREP30DK050306 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI GARY D. WU · 1997 to 2026
$32.5MElectrophysiology of nuclear membrane InsP3 receptorR37GM056328 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI FOSKETT, JAMES KEVIN · 2011 to 2020
$4.9MEndoplasmic Reticulum-to-Mitochondria Calcium Transfer in Pancreatic Cancer Development, Metastasis, and TreatmentR01CA250173 · NCI · UNIVERSITY OF PENNSYLVANIA · PI FOSKETT, JAMES KEVIN · 2021 to 2025
$2.6MInnate Immunity Training ProgramT32AI095213 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SILVERMAN, NEAL · 2011 to 2025
$2.5MIMSD at the University of Massachusetts Medical SchoolT32GM135751 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BRIAN C LEWIS, Kate L Lapane · 2020 to 2026
$2.2MDissecting the oncogenic and pro-metastatic roles of PTHLH-mediated calcium signaling in pancreatic cancerR00CA252153 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI PITARRESI, JASON R. · 2022 to 2024
$747kThe Mitochondrial Calcium Uniporter in Pancreatic Cancer Development, Metastasis, and TreatmentF32CA250144 · NCI · UNIVERSITY OF PENNSYLVANIA · PI WEISSENRIEDER, JILLIAN · 2021 to 2023
$205kNCI NIH HHS F32 CA250144NCI NIH HHS R00 CA252153NCI NIH HHS R01 CA250173NIAID NIH HHS T32 AI095213NIDDK NIH HHS P30 DK050306NIGMS NIH HHS R37 GM056328NIGMS NIH HHS T32 GM135751
Abstract
Endoplasmic reticulum to mitochondria Ca
Indexed as
CalciumCarcinoma, Pancreatic DuctalCell PlasticityEpithelial CellsMitochondriaPancreatic NeoplasmsAnimalsCalcium ChannelsCell Line, TumorCell ProliferationEpithelial-Mesenchymal TransitionHumansMiceNeoplasm MetastasisSnail Family Transcription FactorsTransforming Growth Factor betaCalciumCalcium Channelsmitochondrial calcium uniporterSnail Family Transcription FactorsTransforming Growth Factor betacalcium signalingcancerCP: CancerCP: MetabolismEMTepithelial-to-mesenchymal transitionMCUmetabolismmitochondriapancreasPDACuniporter
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.